Immunotherapy For Pancreatic Cancer Boosts Survival More Than 75 Percent In Mice, Study Finds

Immunotherapy For Pancreatic Cancer Boosts Survival More Than 75 Percent In Mice, Study Finds

Immune mediated therapies for pancreatic cancer have not been overall very effective for the treatment of pancreatic cancer. This study shows that targeting in animals a protein highly expressed in pancreatic cancer with the body’s own defence system may increase effectiveness of chemotherapy. Whether the findings of such as study can be replicated in the human situation is yet to be tested.

You can view the original article at https://www.fredhutch.org/en/news/center-news/2015/10/Immunotherapy-boosts-pancreatic-cancer-survival-study-finds.html

Mouse image courtesy of Stromnes et al./Cancer Cell 2015

Further Reading – References & Resources